Evidence map›Paper›PMID 25274758›Full record

ReviewCold Spring Harbor perspectives in medicine2014

Fungal biofilms, drug resistance, and recurrent infection.

Jigar V Desai, Aaron P Mitchell, David R Andes

Abstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Impact ofmSphere · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. The pathogenicity and future treatment strategies ofFrontiers in cellular and infection microbiology · 2026
    Review
  10. The Potential ofPharmaceutics · 2025
    Article
  11. Article
  12. Review
  13. Acridine Derivatives as Antifungal and Antivirulence Agents AgainstInternational journal of molecular sciences · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. International journal of molecular and cellular medicine · 2025
    Review
  19. DuringAutophagy reports · 2025
    Article
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jigar V DesaiDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213.
Aaron P MitchellDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213.
David R AndesDepartment of Medicine, University of Wisconsin, Madison, Wisconsin 53705.

Funding

Vesicle-mediated drug resistance of Candida albicans biofilmR01AI073289 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ANDES, DAVID R, MITCHELL, AARON P · 2008 to 2025
$7.9M
GENETIC CONTROL OF C. ALBICANS BIOFILM FORMATIONR01AI067703 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MITCHELL, AARON P · 2006 to 2014
$3.2M
NIAID NIH HHS R01 AI067703NIAID NIH HHS R01 AI073289
6 · The paper itself

Abstract

A biofilm is a surface-associated microbial community. Diverse fungi are capable of biofilm growth. The significance of this growth form for infection biology is that biofilm formation on implanted devices is a major cause of recurrent infection. Biofilms also have limited drug susceptibility, making device-associated infection extremely difficult to treat. Biofilm-like growth can occur during many kinds of infection, even when an implanted device is not present. Here we summarize the current understanding of fungal biofilm formation, its genetic control, and the basis for biofilm drug resistance.

Indexed as

Drug Resistance, FungalAspergillus fumigatusBiofilmsCandida albicansCoinfectionExtracellular MatrixGlucansHumansMycosesProsthesis-Related InfectionsRecurrenceGlucans

Identifiers

PMID25274758
PMCPMC4200207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.